3 Reasons Monsanto Company's Stock Could Rise

The leading sustainable agriculture company is presented with several long-term opportunities that could cause its stock to rise.

Aug 25, 2014 at 9:35AM

Can a stock that has risen by over 540% in the last decade really continue to climb? Well, that all depends on the current state of affairs at the company and the market opportunities it can realistically target and capture. When it comes to the sustainable agriculture business of Monsanto Company (NYSE:MON) the future looks pretty bright -- despite the stock's meteoric 10-year rise.

MON Chart

MON data by YCharts

Growth won't be achieved without headwinds, but management's strategy to grow the bottom line in the next five years should catch the eyes of growth and value investors alike. While Monsanto Company's 2010 EPS registered at a respectable $2.39, projects are under way to push 2014 EPS over $5.00 and 2019 EPS over $10.00. That probably grabbed your attention, so let's evaluate three reasons Monsanto Company's stock could rise.

1. Massive opportunities in vegetable seeds

Flavr Savr, the genetically modified tomato, may have been a market dud when introduced in 1994, but Monsanto Company learned from the experience of Calgene (the company it acquired) to develop what may be the world's best cross-breeding platform. It may seem improbable that a company so closely associated with biotech crops could have a substantial future in vegetables -- or would even care about them for that matter -- but it may not be long before the ripest and juiciest peppers, melons, and cabbages in the produce aisle are supplied by Monsanto Company.

Oh, and another thing, they'll be organic.

Third quarter sales of vegetable seeds grew just 2.3% compared to the same period in 2013, but don't write off the segment just yet. As Ben Paynter reported in Wired earlier this year, Monsanto Company has revolutionized cross-breeding by incorporating next-generation biology tools including novel genome sequencing, data analysis, and genetic prediction tools. In other words, Monsanto Company can peer into the genome of, say, a lettuce to determine which regions code for a specific trait and alter the region with software (rather than growing a plant) to determine which changes need to be made to produce the desired trait. Then, researchers can predict which traits will be passed on through breeding, how long it will take, and begin crossing plants to produce the ultimate lettuce. Such a technology platform could create a multi-billion business that becomes the next industry standard.

2. Disruptive pipeline products

The word "game-changer" gets tossed around an awful lot these days, but Monsanto Company really could be sitting on a few different game-changing products. The value is in the company's approach. Similar to the way it transformed agriculture by streamlining pest management systems with Roundup-Ready corn and soybeans, future products will once again challenge the status quo.

The most promising long-term portfolio and product development area lies in microbials, or compounds produced from microorganisms that can be applied to fields to naturally control pests, protect soil, improve productivity, and more. Agricultural biologicals could one day complement or even replace agricultural chemical products such as glyphosate -- reducing environmental impact while increasing yields.


For instance, Monsanto Company's BioDirect brand uses molecules found in nature to create topically applied crop protection products. A microbial pesticide, or biopesticide, could be a Bt spray that controls worms or a spray or seed that incorporates RNAi technology to selectively target viruses that prey upon pollinators such as honeybees. There are currently four BioDirect projects in the pipeline aiming to do just that, but it will be several more years before they're commercially available.

3. Strategic acquisitions paying off

Investors are well aware that the merger with Syngenta is no more, but successful acquisitions in recent years have turned out to be incredibly wise. Some of the BioDirect products in development today came from the acquisition of Beeologics in 2011. Similarly, the company's acquisition of The Climate Corporation in October 2013 is advancing ahead of schedule.

Monsanto Company's climate platform merges big data and agriculture to provide real world recommendations and solutions to farmers in real-time. Simple things such as planting a few days sooner or altering a farm's irrigation schedule could add up to more profitable harvests. It has all of the potential to become the Internet of Things for farmers -- and it's off to an explosive start in 2014. In the first half of the year the number of partners has increased from one to six, which collectively represent over $60 billion in agricultural sales and over 40 million acres of cropland dedicated to the Climate platform.   

Foolish bottom line

Monsanto Company appears to be firing on all cylinders heading into the second half of the decade. With strategic acquisitions and partnerships developing a number of products with multi-billion dollar potential, there are few reasons to doubt that management will meet its 2019 EPS target of $10.00 per share. Of course, Monsanto Company stock could rise or fall for any number of reasons. All investors can do is understand the company and prepare for potential opportunities or headwinds. In the long term, headwinds may be minimized for a business as important as Monsanto's.

Top dividend stocks for the next decade

The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolioCAPS pageprevious writing for The Motley Fool, or his work with SynBioBeta to keep up with developments in the synthetic biology industry.

The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information